Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

39
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
39
Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.6K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.6K
Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

11.2K
In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
11.2K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

445
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
445
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Application of Language Models for the Analysis of Adverse Drug Events in Pharmaceutical Research and Development: Scoping Review.

JMIR AI·2026
Same author

GLiNER-BioMed: a suite of efficient models for open biomedical named entity recognition.

Bioinformatics (Oxford, England)·2026
Same author

The detectability paradox: bilingual medical report generation with open-weight models and the limits of human oversight.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Machine learning for medication error detection: a scoping review protocol.

BMJ open·2026
Same author

In-Vivo Characterization of Healthy Retinal Pigment Epithelium and Photoreceptor Cells from AO-(T)FI Imaging.

Vision (Basel, Switzerland)·2025
Same author

High-Resolution Adaptive Optics Transscleral Flood Illumination Imaging Allows Phenotyping of Age-Related Macular Degeneration.

Cells·2025
Same journal

HIV Transmission Dynamics in Greater Mexico City are Shaped by Dense Spatial Mixing.

Research square·2026
Same journal

A UCP1-IRES-Cre Knock-In Mouse Enables Specific Brown Adipocyte Targeting Without CNS Off-Target Expression.

Research square·2026
Same journal

Precision RNAi for Fibrodysplasia Ossificans Progressiva: a combinatorial, unimolecular, allele selective approach.

Research square·2026
Same journal

Perceptions of end-of-life care quality among bereaved closest contacts of community-dwelling older Australians: a cross-sectional survey of the ASPREE cohort.

Research square·2026
Same journal

Heavy-chain immune repertoire sequencing enables language-model prediction of antigen-specific antibodies.

Research square·2026
Same journal

25+ Years of TRPV4: From Discovery to Translational Horizons.

Research square·2026
查看所有相关文章

相关实验视频

Updated: Feb 28, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

机器学习用于药物错误检测:一个范围审查.

Félicien Hêche, Sohrab Ferdowsi, Anthony Yazdani

    Research square
    |February 27, 2026
    PubMed
    概括
    此摘要是机器生成的。

    机器学习 (ML) 在检测药物错误方面表现有前途,特别是在处方数据方面. 然而,数据质量和现实世界的验证等挑战需要解决,以便在患者安全方面得到更广泛的应用.

    更多相关视频

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
    07:15

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

    Published on: August 16, 2020

    7.6K

    相关实验视频

    Last Updated: Feb 28, 2026

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    8.2K
    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
    07:15

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

    Published on: August 16, 2020

    7.6K

    科学领域:

    • 医疗信息学 医疗信息学
    • 人工智能在医学中的应用
    • 患者安全研究 患者安全研究

    背景情况:

    • 药物错误对公共卫生构成重大风险,传统干预措施的成功程度有限.
    • 机器学习 (ML) 提供先进的计算方法来提高药物安全性.
    • 现有研究强调了ML在识别和预测药物错误方面日益增长的应用.

    研究的目的:

    • 系统地审查和分类基于ML的方法用于药物错误检测和预测.
    • 综合当前的进展,并确定药物安全的ML应用的趋势.
    • 突出ML驱动的药物错误分析中的差距和未来方向.

    主要方法:

    • 在PubMed,Embase和Web of Science (2015年至2025年4月) 进行了全面的文献搜索.
    • 研究是根据按照PRISMA-ScR指南预定义的资格标准进行选择的.
    • 数据提取使用了一个结构化的框架,由两个独立的审查员进行.

    主要成果:

    • 22项研究符合纳入标准,揭示了两个主要的ML管道.
    • 处方错误检测主要使用基于树模型的结构化数据.
    • 使用非结构化的多式联络数据和神经网络来解决药物管理错误.

    结论:

    • ML显示了药物错误检测的巨大潜力,特别是在处方工作流程中.
    • 碎片化的证据,有限的概括性和稀缺的现实世界验证阻碍了当前的ML应用.
    • 未来的进步需要高质量的数据集,透明的验证,以及探索各种数据模式,如自由文本.